Kynam Capital Management, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN)

Filing Manager
Kynam Capital Management, LP
Reporting Manager
Kynam Capital Management, LP
Security
Viridian Therapeutics, Inc. Common Stock, $0.01 par value
Symbol
VRDN
Shares outstanding
95,489,675 shares
Disclosed Ownership
1,470,541 shares
Ownership
1.5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 12:52:53 UTC
Date of event
31 Dec 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kynam Capital Management, LP 1.5% 1,470,541 0 1,470,541 Yue Tang Managing Member
Kynam Capital Management GP, LLC 1.5% 1,470,541 0 1,470,541 Yue Tang Managing Member
Yue Tang 1.5% 1,470,541 0 1,470,541 Yue Tang Self